Laurent Sabbagh

Company: DOMAIN Therapeutics
Job title: Scientific Director
Seminars:
Early-Stage Development of BRET-Based Assays to Characterize the Activation of the Human Adhesion GPCR ADGRE5 9:00 am
Applying mechano-stimulation to study human ADGRE5 activation revealed by BRET-based biosensors Demonstrating the mechanistic aspects of ADGRE5 receptor activation and impact on actin remodeling, exposing a possible mechanism by which hADGRE5 may promote tumor metastasis Showcasing the future for the application of different technologies to study adhesion GPCR biology and develop screening assays to identify…Read more
day: Day One